Table 2.
Antimicrobial Activities of 1–6.
| Organism (strain) | Minimum Inhibitory Concentration (μg/mL) | ||||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | Control | |
| Bacillus Calmette–Guérin (Pasteur 1173P2) | >100 | >100 | >100 | >100 | >100 | >100 | 0.05 a |
| Staphylococcus aureus (ATCC 6538) | >100 | >100 | >100 | >100 | 6.25 | 6.25 | 1 b |
| methicillin-resistant S. aureus (MRSAa) | >100 | >100 | 100 | >100 | 12.5 | 25 | 1 b |
| Bacillus subtilis (ATCC 6633) | >100 | >100 | >100 | >100 | >100 | >100 | 0.5 b |
| Pseudomonas aeruginosa (PAO1) | >100 | >100 | >100 | >100 | >100 | >100 | 1 c |
| Candida albicans (SC 5314) | >100 | >100 | >100 | >100 | 100 | >100 | 0.016 d |
a Isoniazid; b Vancomycin; c Ciprofloxacin; d Ketoconazole.